fashion -WSS

fashion

author：explore 2025-10-02 20:52:30 - browse：8351

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

WSS

FDA's naming rule on biosimilars has undermined competition

Covid vaccine financial winners and losers, from Pfizer to Novavax

Fed up with FDA, ALS advocates consider a take

House panel takes first step toward fixing drug shortages

Why the world’s most expensive drug might be worth the price

Why the world’s most expensive drug might be worth the price

Wikipedia

fashion

A looming test for neoantigen cancer vaccines

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

White House Covid adviser calls on docs to combat misinformation

Medical records are filled with copy

House panel takes first step toward fixing drug shortages

23andMe had bad news about my health. I wish a person had delivered it

Study says nonprofit hospitals fall short in charity care spending

23andMe had bad news about my health. I wish a person had delivered it

Information blocking fines are now fair game in health care

Malaria cases in Florida and Texas: Here’s what you need to know

Washington mulls new rules to avert another Change Healthcare

hotspot

David Liu startup to focus on CRISPR delivery

Covid’s new normal has set in amid another rise in cases

The Readout: Lenmeldy, GLP

Midwives could help bridge maternal health disparities in the U.S.

Midwives could help bridge maternal health disparities in the U.S.

Primary care physicians play key roles in Alzheimer's management

knowledge

Wikipedia

hotspot

hotspot